News
12 May 2026
Frost & Sullivan’s 2026 Global Company of the Year
Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.
11 September 2026
Avance Clinical Wins ANZCham’s Australia-Taiwan Business Excellence Award in Taiwan
Avance Clinical Taiwan has won the Australia-Taiwan Business Excellence Award at the 2026 Australia New Zealand Chamber of Commerce in Taiwan.
24 August 2026
Avance Clinical Appoints Inaugural Chief Commercial Officer, Reinforcing Global Growth Strategy
Avance Clinical today announced the appointment of Tim Schuckman as its first Chief Commercial Officer (CCO).
29 July 2026
Korea University Medicine, Taiwan Alliance of Clinical Trial Centers, and Avance Clinical Convene Regional Collaboration Event in Seoul
Korea University Medicine, TACTC and Avance Clinical met in Seoul to strengthen Asia-Pacific clinical research and drug development partnerships.
21 July 2026
Avance Clinical and Dongguk University Establish Strategic Partnership to Develop Future Clinical Research Talent
Dongguk University and Avance Clinical sign an MOU to strengthen industry-academia collaboration and develop future pharma and biotech talent.
10 July 2026
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026
Global CRO highlights multi-regional trial delivery, early-phase Australia advantages, and expanding support for biotech sponsors across Asia and China.
22 June 2026
Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026
Global CRO expands its operational footprint into Singapore and Malaysia, strengthens China presence, and grows India operations - creating a powerhouse in the Asia Pacific region.
19 May 2026
Avance Clinical to Showcase Oncology Leadership at ASCO Annual Meeting 2026
Avance Clinical will engage with biotech sponsors to discuss strategies for delivering efficient, high-quality oncology trials spanning first-in-human through to later-phase proof of concept global programs.
12 May 2026
Frost & Sullivan’s 2026 Global Company of the Year
Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.
18 March 2026
Avance Clinical Appoints Liahna Toy to Lead Global Early Phase Center of Excellence
Avance Clinical, a global full-service CRO headquartered in Australia dedicated to servicing biotech, announces the appointment of Liahna Toy as Senior Vice President & Head of Early Phase Center of Excellence, reinforcing the company’s strategic focus on accelerating high-quality early-phase trials for emerging biotech sponsors.
7 January 2026
Avance Clinical Strengthens Global Oncology Offering with Acquisition of U.S-Based LumaBridge
Avance Clinical today announced the acquisition of LumaBridge, a specialized U.S.-based clinical CRO with deep expertise in oncology trials.
6 November 2025
Avance Clinical Launches Diversity in STEM Scholarships Across Australia and North America
Avance Clinical has announced the launch of its new Diversity in STEM Scholarships.
3 November 2025
Avance Clinical Showcases Early Phase Expertise and the Australian Advantage for EU Biotechs at BIO-Europe Vienna
Helping European Biotechs Accelerate Early Phase Success With Faster Timelines, Lower Costs, and Globally Accepted Data
Proven industry
experience & expertise
500+
Studies in the past 5 years
450+
Experienced team members
18k+
Participants past 5 years
30
Years of CRO experience